Postural Spirometry Changes in Ambulatory Myotonic Dystrophy Patients
Lung Function Impairment and Postural Spirometry Changes in Ambulatory Myotonic Dystrophy Patients
1 other identifier
interventional
58
1 country
1
Brief Summary
Myotonic dystrophy Type 1 (MD1, Steinert's disease), an autosomal dominant multisystem disease, is of the most common muscular dystrophies in adults, with a European prevalence of 3-15/100 000. The disease course is progressive, associating muscular weakness, wasting and myotonia. Respiratory dysfunction is common, involving a restrictive ventilatory abnormality and alveolar hypoventilation, originating from respiratory muscle weakness. Depending on the degree of impairment of their lung function, the quality of life and the prognosis of MD1 patients may be very variable. However, time course and prevalence of such respiratory function impairment have not been clearly identified. More importantly, factors able to predict poor respiratory outcome have not been defined and therefore early prognosis can not be assessed during the follow-up of these patients. In other neuromuscular disorders, especially Amyotrophic Lateral Sclerosis (ALS), postural spirometry has been recommended to improve the detection of diaphragmatic involvement and some authors have suggested that the supine fall in the forced vital capacity could be used to initiate noninvasive positive pressure ventilation and predicts some respiratory symptoms. In a sample of ambulatory patients with MD1, our study was designed to prospectively achieve two aims: 1) to assess the respective prevalence of a ventilatory restrictive pattern, respiratory muscle weakness, hypoxemia and hypercapnia and 2) to evaluate whether postural changes in lung volumes contribute to sensitize the diagnosis of respiratory weakness and could be used as a predictor of poor respiratory function, including hypoxemia, hypercapnia and restrictive ventilatory disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2008
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2010
CompletedFirst Submitted
Initial submission to the registry
November 15, 2010
CompletedFirst Posted
Study publicly available on registry
November 16, 2010
CompletedNovember 16, 2010
November 1, 2010
2.2 years
November 15, 2010
November 15, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evidence of lung function impairment
Evidence of ventilatory restriction assessed by lung function testing or hypoxemia or hypercapnia assessed by arterial blood gases analysis
1 year on average (annual regular follow-up)
Secondary Outcomes (1)
predictive factors of lung function impairment
1 year on average (annual regular follow-up)
Interventions
In addition to the current upright lung function evaluation we performed a supine spirometry
Eligibility Criteria
You may qualify if:
- clinical diagnosis of myotonic dystrophy type 1
- years of age and older
- must be able to perform reproducible ventilatory manoeuvres
You may not qualify if:
- required non-invasive ventilation
- non reproducible spirometry results
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Nancylead
- Central Hospital, Nancy, Francecollaborator
Study Sites (1)
University Hospital of Nancy
Vandœuvre-lès-Nancy, 54511, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bruno Chenuel, MD, PhD
University of Nancy
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
November 15, 2010
First Posted
November 16, 2010
Study Start
April 1, 2008
Primary Completion
June 1, 2010
Study Completion
June 1, 2010
Last Updated
November 16, 2010
Record last verified: 2010-11